Microscopic Colitis
Microscopic Colitis is a research topic within Epidemiology. Science Explorer counts 28k research works in it since 1950. 18.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, pathophysiology, diagnosis, and treatment of microscopic colitis, including collagenous colitis and lymphocytic colitis. It covers topics such as budesonide treatment, histological features, drug-induced colitis, and the association with other gastrointestinal tract disorders and inflammatory bowel disease. The papers also discuss the impact of proton pump inhibitors and other medications on the development of microscopic colitis.
- Microscopic Colitis
- Collagenous Colitis
- Lymphocytic Colitis
- Budesonide Treatment
- Epidemiological Study
- Histological Features
- Drug-Induced Colitis
- Gastrointestinal Tract Disorders
- Inflammatory Bowel Disease
- Proton Pump Inhibitors
- Research works
- 28k fractional, since 1950
- In the world top 10%
- 5.3k per year above
- Top-10% rate
- 18.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +21% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Microscopic Colitis research?
By volume, the United States and China publish the most (1.3k and 366 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.3k works
- 2 China 366 works
- 3 United Kingdom 305 works
- 4 Italy 262 works
- 5 Spain 217 works
- 6 Japan 191 works
- 7 Germany 179 works
- 8 Canada 178 works
- 9 India 130 works
- 10 Australia 123 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Microscopic Colitis research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Microscopic Colitis research, followed by Icahn School of Medicine at Mount Sinai and Cleveland Clinic.
By volume, 2022–2025
- 1 University of North Carolina at Chapel Hill United States 37 works
- 2 Icahn School of Medicine at Mount Sinai United States 36 works
- 3 Cleveland Clinic United States 31 works
- 4 University of Chicago United States 25 works
- 5 University of Calgary Canada 21 works
- 6 KU Leuven Belgium 19 works
- 7 Mayo Clinic in Arizona United States 19 works
- 8 Harvard University United States 18 works
- 9 Mayo Clinic United States 17 works
- 10 Ain Shams University Egypt 15 works
Who are the leading researchers in Microscopic Colitis?
The most-cited researchers publishing on Microscopic Colitis include Dan J. Stein, Reza Malekzadeh and Hermann Brenner.
- 1 Dan J. Stein 7.7k citations
- 2 Reza Malekzadeh 6.7k citations
- 3 Hermann Brenner 5.8k citations
- 4 Peter R. Galle 3.3k citations
- 5 Ramnik J. Xavier 3k citations
- 6 Stefan Schreiber 2.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Microscopic Colitis research done?
The largest centres of Microscopic Colitis research in 2022–2025 are New York (United States), London (United Kingdom), Cleveland (United States) and Madrid (Spain).
Largest cities, 2022–2025
Where is the best place to study Microscopic Colitis?
Among universities, judged by research, Icahn School of Medicine at Mount Sinai, Medical University of Lodz and University of Chicago score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Icahn School of Medicine at Mount Sinai United States | 68.1 | 19.3% | 15.4× | 36 | +63.0% |
| 2 | Medical University of Lodz Poland | 63.1 | 32.5% | 11.3× | 8 | +127.8% |
| 3 | University of Chicago United States | 55.7 | 24.6% | 6.3× | 25 | +55.8% |
| 4 | Harvard University United States | 50.9 | 28.9% | 2.9× | 18 | +74.0% |
| 5 | University of Calgary Canada | 50.3 | 16.5% | 6.9× | 21 | +36.9% |
| 6 | Western University Canada | 49.6 | 22.3% | 5.3× | 14 | +99.0% |
| 7 | KU Leuven Belgium | 49.1 | 22.6% | 4.5× | 19 | +28.5% |
| 8 | University of Otago New Zealand | 45.4 | 19.9% | 7.3× | 10 | +38.0% |
| 9 | Karolinska Institutet Sweden | 45.2 | 27.3% | 4.8× | 10 | -22.2% |
| 10 | Tel Aviv University Israel | 40.7 | 14.1% | 4.8× | 12 | +125.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Microscopic Colitis research growing?
Output in 2018–2022 was 21% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Microscopic Colitis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.